Aug 03, 2021 08:00 AM

Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 31.5 Million Yuan Net Profit in First Half of 2021

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net profit of 31.5 million yuan in the first half of 2021, reversing a net loss of 2.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 612 million yuan in revenue, up 2.2% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 766.4 million yuan in total liabilities, with a liability-to-asset ratio of 24.8%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin China Biz Roundup: Rape Allegations at Acting School Spark Uproar